CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3,002 enrolled
Drug / intervention
GIFTgenetic
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05552664
NCT05552664N/ACompleted
CompareCT.gov

The Genetic Information and Family Testing (GIFT) Study

University of Michigan Rogel Cancer Center·interventional·Posted Sep 23, 2022·Updated Jan 26, 2026

In Brief

A clinical study evaluating GIFT for Cancer. Completed, enrolled 3,002 participants across 4 sites.

Detailed Summary

The Genetic Information and Family Testing (GIFT) Study is designed to support the capacity, opportunity, and motivation of cancer patients to engage their relatives about inherited cancer susceptibility and provide support and services to those relatives to initiate GRE (including genetic testing) and prepare them to subsequently engage their clinicians in informed decision-making about cancer prevention and early detection.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
2023202420252026
First PostedSep 23, 2022
Enrollment StartOct 24, 2022
Primary CompletionJul 10, 2025
Study CompletionAug 10, 2025
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 3.8 years ago

Interventions

GIFTgenetic

GIFT features a web-based intervention that offers access to an online family communication program containing key facts about genetics, cancer risk, and the role of genetic testing and helps patients share health information with their first-and second-degree relatives, whom they can invite to join the study to receive education/support and access to low-cost genetic testing.